Document Detail

Successful management of a viable cervical pregnancy by single-dose methotrexate.
MedLine Citation:
PMID:  10718504     Owner:  NLM     Status:  MEDLINE    
Cervical pregnancy is very uncommon and carries a high risk for hysterectomy with surgical treatment. Prior reports of medical treatment included various regimens of high-dose systemic methotrexate (MTX) with citrovorum rescue and local injection. This is the first report of successfully treating a viable cervical pregnancy with single-dose i.m. MTX, followed by a vaginal delivery.
J M Goldberg; T Widrich
Related Documents :
17912694 - The management of cesarean scar ectopic pregnancy following treatment with methotrexate...
24561224 - Yolk contributes steroid to the multidimensional endocrine environment of embryos of ni...
8355474 - Laparoscopic treatment of ectopic pregnancies--reports of two cases.
17418394 - Management of ruptured corpus luteum cyst of pregnancy occurring in a 15-year-old girl ...
9214424 - Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients.
3225724 - The rationale for biochemical monitoring of the fetus.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of women's health & gender-based medicine     Volume:  9     ISSN:  1524-6094     ISO Abbreviation:  J Womens Health Gend Based Med     Publication Date:    2000 Jan-Feb
Date Detail:
Created Date:  2000-04-07     Completed Date:  2000-04-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100888719     Medline TA:  J Womens Health Gend Based Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  43-5     Citation Subset:  IM    
Department of Gynecology, The Cleveland Clinic Foundation, Ohio 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents, Nonsteroidal / administration & dosage*
Cervix Uteri
Injections, Intramuscular
Methotrexate / administration & dosage*
Pregnancy, Ectopic / drug therapy*
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Menstrual patterns during the inception of perimenopause: what are the predictors and what do they p...
Next Document:  Acceptability of human papillomavirus immunization.